Share on LinkedInShare on LinkedIn

ARTICLE · 15 DECEMBER 2011

Defective Hip Replacements – Implications for Doctors and Hospitals

The hip replacement devices have failed at a higher rate, and have released cobalt and chromium into patient tissues.

AustraliaConsumer Protection

The recall of DePuy metal on metal hip replacements (manufactured by Johnson & Johnson Medical and implanted in approximately 5,500 Australian patients) has been widely publicised. The devices have been found to fail at a much higher rate than normal, and also to have released concerning levels of cobalt and chromium into the tissues of patients.

The higher than anticipated rate of repeat surgery was first noted by the Australian Joint Replacement Registry (AJRR) in patients with the implant in 2006. This was communicated to the Therapeutic Goods Authority (TGA). Higher failure rates were confirmed by the AJRR in 2007, and again communicated to the TGA. The TGA established an expert advisory group, and after a series of further reviews recommended in December 2009 that the product be withdrawn.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from